Investing
Science Corporation, a competitor of Elon Musk's Neuralink, offers a brain-computer interface retinal implant designed to restore vision in patients with macular degeneration.
The Massachusetts-based company will use the funds to advance its Spectris neurotechnology platform that uses visual and auditory stimulation to treat Alzheimer's disease.
The company will use the funds to expand its platform that connects caregivers, care teams and residents in senior living and long-term care facilities.
The company offers agentic AI agents designed to assist healthcare teams with tasks such as patient scheduling, intake, insurance verification and patient outreach.
The New York-based company will use the funds to expand its in-person and online therapy platform.
The new funding brings the company's total raise to more than $55 million.
The funds will be used to enhance the company's hybrid human and AI-powered operating platform, scale its reach and grow its workforce.
Also, Wellumio has received $4 million in pre-Series A funding to further develop its portable, AI-augmented brain scanner.
Also, an Indian sleep tech startup is headingo the United States after raising $3 million in seed funding.
ProSommus Sleep Technologies secured $38 million, Rainfall Health closed a $15 million Series A round and Synchrony Medical closed a $5 million funding round.